YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.
YGION Biomedical has raised $16.3M in total funding. The most recent round was Series A. The last funding was announced in May 2024.
YGION Biomedical is headquartered in Vienna, Austria.
YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.
YGION Biomedical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"YGION Biomedical — Funding & Investors." VCBacked, May 21, 2024, https://www.vcbacked.co/company/ygion-biomedical. Accessed September 30, 2026.
VCBacked. (2024). YGION Biomedical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/ygion-biomedical
{{cite web |title=YGION Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/ygion-biomedical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated